mesowatch
HomeWashington Court Confirms $17M Mesothelioma Verdict
divider

Washington Court Upholds $17M Verdict in Mesothelioma Suit

mesothelioma jury verdict

In a recent ruling, a Washington appeals court upheld a nearly $17 million jury verdict against a paper mill supplier accused of causing a worker’s mesothelioma with its asbestos-laden product. The court rejected the supplier’s claims that the case was based on “pure speculation.”

Details of the Asbestos Exposure Case

The verdict was awarded to Sherrie D. Holdsworth, who continued the lawsuit filed jointly with her late husband, Kevan A. Holdsworth, after his passing. Kevan, a former mill worker, contracted mesothelioma from products produced by Scapa Waycross Inc., according to the court’s findings.

Scapa Waycross argued that the trial judge should have ruled in its favor, as Sherrie Holdsworth allegedly relied on speculation rather than proving her husband’s exposure to asbestos. However, the appeals court disagreed, stating that there was sufficient evidence for the jury’s decision.

Evidence of Asbestos Exposure

Kevan Holdsworth had been exposed to asbestos during his decades-long career at a paper mill in Camas, Washington. He worked with dryer felts manufactured by Scapa Waycross, which contained asbestos. Despite Scapa’s arguments, the court found that the evidence supported the conclusion that the felts caused Holdsworth’s illness.

The court’s decision upheld the jury’s award and denied Scapa Waycross’s requests for a new trial or judgment as a matter of law. The ruling highlights the importance of considering the proximity, duration, and nature of asbestos exposure in such cases.

Johnathan Edwards

Reading Time: 1 mins

Published On: March 14, 2023

Johnathan Edwards - author

Johnathan Edwards Is a husband, father, veteran and medical writer, from the state of California. After serving 9 years in the U.S Army Medical Department, John cultivated his passion for serving his country and helping people. He often volunteers with helping to rehabilitate veterans of all ages. After John’s father was diagnosed with Mesothelioma, he began to research, write and fight for ways to help other victims of asbestos exposure.

More to Read

Section Divider

Amna Anees - November 17, 2024

CHMP Recommends Pembrolizumab and Chemo for Pleural Mesothelioma

Mini Divider
Mesowatch Logo

Mesowatch serves as an industry watchdog and advocates for patients and families affected by asbestos by providing reliable and up-to-date news stories and information on asbestos and mesothelioma.

NAVIGATE

About UsEditorial GuidelinesNewsSupport and ResourcesPrivacy PolicySitemap

CONTACT US

Email: support@mesowatch.com

Phone: (866) 402-1000

Address: 3260 N Hayden Rd, Suite 210, Scottsdale, AZ 85251

Copyright © 2024 by Mesowatch. All Rights Reserved.
At Mesowatch, we strive to provide helpful information for your journey. Please remember that the content on our website is for informational purposes only and is protected by copyright law. It is not a substitute for professional medical or legal advice. We encourage you to consult qualified professionals for any health or legal concerns. Disclaimer